Dry Needling: What it is it? & When to use it?

---

Overview

Dry needling electro-therapy uses very thin medical needles connected to gentle electrical stimulation to help reduce pain—whether it’s new (acute) or long‑standing (chronic)—and to support rehabilitation and return to activity. Many patients come to us for DN‑ET on the recommendation of their physician or physical therapist when pain persists despite standard care.

DN‑ET targets tight, irritable bands in muscle (often called trigger points or myofascial pain generators) that may be sending ongoing pain signals to the nervous system. By treating these areas, we aim to dial down “overactive” pain processing in the brain and spinal cord and help the body move more freely with less discomfort.

Patients frequently ask how this differs from traditional acupuncture. DN‑ET is a biomedically framed procedure: it’s guided by anatomy, tissue pathology, and movement findings—not by Traditional Chinese Medicine (TCM) pattern diagnosis—although many DN‑ET sites overlap with classical acupuncture point locations. Dr. Heide explains each step in biomedical terms so patients understand what’s being treated and why.

Conceptual Model
DN‑ET is an evidence‑based intervention that maps myofascial trigger point models onto contemporary pain science. The goal: reduce peripheral nociceptive drive and downstream central sensitization, including activity in brain regions such as the anterior cingulate cortex and modulation within descending inhibitory pathways.

Peripheral / Mechanical Actions

• Needle insertion plus e‑stim mechanically disrupts persistent contracture within taut bands.
• Induces stretch and length change in shortened sarcomere assemblies, decreasing excessive actin–myosin overlap.
• May modulate dysfunctional motor endplates; emerging data suggest effects on focal denervation / reinnervation phenomena relevant to pain and tissue recovery.
   

Neurochemical & Neurophysiologic Modulation
Dose‑dependent electrostimulation parameters have been associated with:

• Local and segmental analgesia.
• Central neuroplastic responses, including altered pain sensitivity.
• Release of endogenous inhibitory mediators (endorphins, enkephalins, GABA, galanin, dynorphins).
• Shifts in pro‑ and anti‑nociceptive signaling molecules: substance P, CGRP, β‑endorphin, TNF‑α, and related inflammatory mediators—mechanisms thought to contribute to reduced central nervous system hyperexcitability.
   

Clinical Indications in Our Setting
Primary use: pain management and functional rehabilitation across acute and chronic presentations, frequently in collaboration with referring MDs, DOs, physiatrists, and physical therapists.

Integration & Communication
Although rooted in biomedical diagnosis, DN‑ET shares anatomical overlap with many classical acupuncture channels/points. When helpful for patient understanding, these parallels are noted—but treatment decisions are guided by orthopedic findings, tissue load, and pain mechanisms. This transparent, education‑forward approach improves patient engagement and adherence, and supports coordinated care across disciplines.

 DN‑ET provides a targeted, research‑supported way to calm trigger point–driven pain, interrupt nociceptive signaling, and support recovery—delivered in a biomedical framework that aligns with physician and physical therapy care plans while remaining accessible to patients. Let us know if you’d like parameter ranges, citation lists, or referral note language.